Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention
about
Tenofovir-based pre-exposure prophylaxis for HIV preventionSystematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directionsHIV-1 prevention for HIV-1 serodiscordant couplesAntiretroviral prophylaxis for HIV prevention in heterosexual men and womenPre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trialsThe 15th Bangkok International Symposium on HIV MedicineSingle-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.Biomarker evaluation of self-reported condom use among women in HIV-discordant couples.'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnershipsPreferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couplesHigh medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis."Maybe his blood is still strong": a qualitative study among HIV-sero-discordant couples on ART in rural Uganda.Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected menPreexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraceptionAssociation between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples.Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trialPregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trialMannose-binding lectin and ficolin-2 do not influence humoral immune response to hepatitis B vaccine.A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy.Fertility Decision-Making Among Kenyan HIV-Serodiscordant Couples Who Recently Conceived: Implications for Safer Conception PlanningWillingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.Oral antiretroviral chemoprophylaxis: current status.Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis.Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant PartnershipsPrevalence and predictors of HIV sero-discordance among cohabiting couples tested in northern Tanzania.Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration.An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention.Fertility intentions and interest in early antiretroviral therapy among East African HIV-1-infected individuals in serodiscordant partnerships.Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected PersonsUse of antiretrovirals for HIV prevention: what do we know and what don't we know?Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.Increasing extracellular protein concentration reduces intracellular antiretroviral drug concentration and antiviral effect.Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women.Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial
P2860
Q22242692-9CED6DAE-EF82-409C-BB0F-32EDAF4FAF85Q26825862-8FDD3553-53DE-454D-A7D8-2BA964AC6FE4Q26996011-7D45C7E7-0BE8-4702-AE84-BC5882A5CA2FQ28270788-612402E1-286E-4026-A19C-999CE9908413Q28539443-8CEEBC6E-B567-4E5B-96D3-74E51D44D490Q29396779-FB75CC89-2638-411E-BE4D-5FD33D8475C6Q30858811-D77C4F80-420A-4C8A-B71F-99BA93B0DD70Q33553976-FC9CB3AA-3EBC-4CEE-8C6F-B3717AAE21B2Q33693690-025B93E7-290B-4CA9-B897-8D5C1204C804Q33733039-EDE4AFFC-662B-4B28-977B-1DE2464A7911Q33831463-7069D3FA-5F67-4129-97F3-D99F57C5E463Q34021932-6CD5BF91-F0DF-4B2E-A0CB-C3F97BE5F11CQ34110847-F7378F00-E93F-4AA7-8E0F-46BACA4E0F97Q34416502-FE0A68D2-264B-4BF2-B2F3-F7FC0E7BA430Q34436959-50FA7752-436A-4AB6-AE3A-8967B6F857FDQ34700364-6F8F85AF-B3F3-4117-BB66-B2609EFAB328Q34738291-CB58DA30-AD1C-4627-B59B-95674F652EBCQ35163040-3EC9345F-2CF7-4E42-8946-9BCA0B337A97Q35184560-4B86E3A9-014D-4D48-8D8D-530E749506D5Q35218090-1EA0A8DB-1030-4C95-A778-D9D28C84DE61Q35882621-34BEF96F-9E6F-41A1-86E3-DD9655F96A97Q36006803-4879F374-7A70-43A1-857C-877AB8DBB55AQ36188123-644E3CDD-5228-4566-85EC-47EC2B7837A7Q36343568-1D9B98A9-1489-4D88-813A-E8F1BD77603CQ36409225-BB45E372-30A9-4852-9362-E6D9791599EBQ36493442-8D47ABD3-D6B0-468E-B17F-A1A00126C6CBQ36509801-E2E93BA8-BFCB-4F6A-83DA-0E29BE1AA795Q36602040-707C0E5E-79F6-4AD9-8445-F6D5DF024D4BQ36612327-DDFBC326-E99D-469E-B53C-186E7D573710Q36667153-1B01DF2E-6C51-45E2-9C61-2202CD4A51EDQ36750843-DCE139FB-AAF5-447C-ABC1-D92407409132Q36760734-EBC487E3-76CB-45ED-9E83-9EF7C7381C7BQ36812840-6F52EEA7-6C74-4988-8E70-3360E4E0B4E2Q36816377-B2AD7499-0279-4493-9475-6E41E68FA343Q37061624-0C400A8E-4BEE-425F-BBF7-5680F00B4277Q37258762-A8812FE0-957C-41B5-B41F-851860DDC361Q37266072-9C1A7796-2CD7-499E-AAD2-3AB1DE8B15D9Q37341579-BA9895C1-135D-42C1-9038-4DA49CC7CA61Q37409772-87265D6D-1CEC-4DBA-AC7F-D20FFEF52CDBQ37441854-A807A296-EEC2-4F23-9333-DC4669530990
P2860
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@ast
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@en
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@nl
type
label
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@ast
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@en
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@nl
prefLabel
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@ast
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@en
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Characteristics of HIV-1 serod ...... ophylaxis for HIV-1 prevention
@en
P2093
Andrew Mujugira
Carey Farquhar
Charlotte Ingram
Dana Panteleeff
Edwin Were
Elioda Tumwesigye
Heena Shah
Jairam R Lingappa
James D Campbell
James Kiarie
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0025828
P407
P50
P577
2011-01-01T00:00:00Z